Current Edition

Lactohale 206, a new tool for QbD for Dry Powder Inhalation

The DFE Pharma product portfolio for Dry Powder Inhalation contains a full range of lactose grades with different properties, which can be further optimised in collaboration with our customers. DFE Pharma proudly presents you the latest high-quality inhalation grade lactose: Lactohale® 206, a coarse milled alpha-monohydrate lactose without any fine lactose particles.
The mean particle size of this product can be tightly controlled between 75 and 95 µm, by milling to match the customer’s requirements.
The application of Lactohale® 206 provides a tool to explore the Quality-by-Design space of their Dry Powder Inhalation formulation: R&D teams can further optimise their inhaled formulation for flow and deposition by blending Lactohale® 206 with one of the fine grades of DFE Pharma (for example with Lactohale® 210, 220, 230 or 300). Lactohale® 206 is therefore especially of interest for formulators who are in early stage of development process or others who want to explore the design space of their formulation.
Lactohale® 206 is available as a standard grade or can be customised on request, to meet your specific requirements for your DPI formulation. For more information or to request a sample, please visit us at